Alternative promoter usage of the membrane glycoprotein CD36

BMC Molecular Biology

Volumn 7, Issue , 2006, Pages

  Andersen, Malin ^a,c   Lenhard, Boris ^b   Whatling, Carl ^c,d   Erikssson, Per ^c   Odeberg, Jacob ^a,c  

^a ALBANOVA UNIVERSITY CENTER   (Sweden)

^b UNIVERSITY OF BERGEN   (Norway)

^c KAROLINSKA INSTITUTE   (Sweden)

^d ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD36 ANTIGEN; DNA; ISOPROTEIN; MEMBRANE PROTEIN; MESSENGER RNA; OXIDIZED LOW DENSITY LIPOPROTEIN;

ADIPOSE TISSUE; ANGIOGENESIS; ANTIGEN EXPRESSION; ARTICLE; ATHEROSCLEROSIS; BRAIN TISSUE; CELL ACTIVITY; CELL ADHESION; CELL SPECIFICITY; CELL TYPE; CONTROLLED STUDY; CPG ISLAND; DNA FLANKING REGION; EXON; GENE EXPRESSION PROFILING; GENE FUNCTION; GENETIC REGULATION; HEART MUSCLE; HEMOSTASIS; HOUSEKEEPING GENE; HUMAN; HUMAN CELL; IMMUNOREGULATION; LIPID TRANSPORT; LIVER PARENCHYMA; MACROPHAGE; MOLECULAR MECHANICS; MONOCYTE; NUCLEOTIDE SEQUENCE; PLACENTA; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; SPINAL CORD; TATA BOX; TISSUE SPECIFICITY; TISSUE TYPES; UPREGULATION;

ADIPOSE TISSUE; ALTERNATIVE SPLICING; ANTIGENS, CD36; CELLS, CULTURED; EXONS; GENE EXPRESSION REGULATION; HUMANS; LIPOPROTEINS, LDL; LIVER; MACROPHAGES; MONOCYTES; MUSCLE PROTEINS; MUSCLE, SKELETAL; MYOCARDIUM; NERVE TISSUE PROTEINS; ORGAN SPECIFICITY; PLACENTA; PROMOTER REGIONS, GENETIC; REGULATORY SEQUENCES, NUCLEIC ACID; SPINAL CORD; TELENCEPHALON;

EID: 33744946520     PISSN: 14712199     EISSN: 14712199     Source Type: Journal    
DOI: 10.1186/1471-2199-7-8     Document Type: Article

References (38)

1. Silverstein RL, Febbraio M: CD36 and atherosclerosis. Curr Opin Lipidol 2000, 11(5):483-491.
2. Nicholson AC, Hajjar DP: CD36, oxidized LDL and PPAR gamma: pathological interactions in macrophages and atherosclerosis. Vascul Pharmacol 2004, 41(4-5):139-146.
3. Greenwalt DE, Lipsky RH, Ockenhouse CF, Ikeda H, Tandon NN, Jamieson GA: Membrane glycoprotein CD36: a review of its roles in adherence, signal transduction, and transfusion medicine. Blood 1992, 80(5):1105-1115.
4. Tanaka T, Nakata T, Oka T, Ogawa T, Okamoto F, Kusaka Y, Sohmiya K, Shimamoto K, Itakura K: Defect in human myocardial long-chain fatty acid uptake is caused by FAT/CD36 mutations. J Lipid Res 2001, 42(5):751-759.
5. Heron-Milhavet L, Haluzik M, Yakar S, Gavrilova O, Pack S, Jou WC, Ibrahimi A, Kim H, Hunt D, Yau D, Asghar Z, Joseph J, Wheeler MB, Abumrad NA, LeRoith D: Muscle-specific overexpression of CD36 reverses the insulin resistance and diabetes of MKR mice. Endocrinology 2004, 145(10):4667-4676.
6. Bonen A, Parolin ML, Steinberg GR, Calles-Escandon J, Tandon NN, Glatz JF, Luiken JJ, Heigenhauser GJ, Dyck DJ: Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36. Faseb J 2004, 18(10):1144-1146.
7. Sugano R, Yamamura T, Harada-Shiba M, Miyake Y, Yamamoto A: Uptake of oxidized low-density lipoprotein in a THP-1 cell line lacking scavenger receptor A. Atherosclerosis 2001, 158(2):351-357.
8. Singh Ahuja H, Liu S, Crombie DL, Boehm M, Leibowitz MD, Heyman RA, Depre C, Nagy L, Tontonoz P, Davies PJ: Differential effects of rexinoids and thiazolidinediones on metabolic gene expression in diabetic rodents. Mol Pharmacol 2001, 59(4):765-773.
9. Kashiwagi H, Tomiyama Y, Kosugi S, Shiraga M, Lipsky RH, Nagao N, Kanakura Y, Kurata Y, Matsuzawa Y: Family studies of type II CD36 deficient subjects: linkage of a CD36 allele to a platelet-specific mRNA expression defect(s) causing type II CD36 deficiency. Thromb Haemost 1995, 74(2):758-763.
10. Imai M, Tanaka T, Kintaka T, Ikemoto T, Shimizu A, Kitaura Y: Genomic heterogeneity of type II CD36 deficiency. Clin Chim Acta 2002, 321(1-2):97-106.
11. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, Haussler D: The human genome browser at UCSC. Genome Res 2002, 12(6):996-1006.
12. Armesilla ALVM: Structural organization of the gene for human CD36 glycoprotein. J Biol Chem 1994, 269(29):18985-18991.
13. Zingg JM, Ricciarelli R, Andorno E, Azzi A: Novel 5′ exon of scavenger receptor CD36 is expressed in cultured human vascular smooth muscle cells and atherosclerotic plaques. Arterioscler Thromb Vasc Biol 2002, 22(3):412-417.
14. Sato O, Kuriki C, Fukui Y, Motojima K: Dual promoter structure of mouse and human fatty acid translocase/CD36 genes and unique transcriptional activation by peroxisome proliferator-activated receptor alpha and gamma ligands. J Biol Chem 2002, 277(18):15703-15711.
15. Noushmehr H, D'Amico E, Farilla L, Hui H, Wawrowsky KA, Mlynarski W, Doria A, Abumrad NA, Perfetti R: Fatty acid translocase (FAT/CD36) is localized on insulin-containing granules in human pancreatic beta-cells and mediates fatty acid effects on insulin secretion. Diabetes 2005, 54(2):472-481.
16. Han J, Hajjar DP, Febbraio M, Nicholson AC: Native and modified low density lipoproteins increase the functional expression of the macrophage class B scavenger receptor, CD36. J Biol Chem 1997, 272(34):21654-21659.
17. Andersson T, Borang S, Larsson M, Wirta V, Wennborg A, Lundeberg J, Odeberg J: Novel candidate genes for atherosclerosis are identified by representational difference analysis-based transcript profiling of cholesterol-loaded macrophages. Pathobiology 2002, 69(6):304-314.
18. CAGE Basic Viewer [http://fantom31p.gsc.riken.jp/cage/hg17/]
19. Carninci P, Kasukawa T, Katayama S, Gough J, Frith MC, Maeda N, Oyama R, Ravasi T, Lenhard B, Wells C, Kodzius R, Shimokawa K, Bajic VB, Brenner SE, Batalov S, Forrest AR, Zavolan M, Davis MJ, Wilming LG, Aidinis V, Allen JE, Ambesi-Impiombato A, Apweiler R, Aturaliya RN, Bailey TL, Bansal M, Baxter L, Beisel KW, Bersano T, Bono H, Chalk AM, Chiu KP, Choudhary V, Christoffels A, Clutterbuck DR, Crowe ML, Dalla E, Dalrymple BP, de Bono B, Della Gatta G, di Bernardo D, Down T, Engstrom P, Fagiolini M, Faulkner G, Fletcher CF, Fukushima T, Furuno M, Futaki S, Gariboldi M, Georgii-Hemming P, Gingeras TR, Gojobori T, Green RE, Gustincich S, Harbers M, Hayashi Y, Hensch TK, Hirokawa N, Hill D, Huminiecki L, Iacono M, Ikeo K, Iwama A, Ishikawa T, Jakt M, Kanapin A, Katoh M, Kawasawa Y, Kelso J, Kitamura H, Kitano H, Kollias G, Krishnan SP, Kruger A, Kummerfeld SK, Kurochkin IV, Lareau LF, Lazarevic D, Lipovich L, Liu J, Liuni S, McWilliam S, Madan Babu M, Madera M, Marchionni L, Matsuda H, Matsuzawa S, Miki H, Mignone F, Miyake S, Morris K, Mottagui-Tabar S, Mulder N, Nakano N, Nakauchi H, Ng P, Nilsson R, Nishiguchi S, Nishikawa S, Nori F, Ohara O, Okazaki Y, Orlando V, Pang KC, Pavan WJ, Pavesi G, Pesole G, Petrovsky N, Piazza S, Reed J, Reid JF, Ring BZ, Ringwald M, Rost B, Ruan Y, Salzberg SL, Sandelin A, Schneider C, Schonbach C, Sekiguchi K, Semple CA, Seno S, Sessa L, Sheng Y, Shibata Y, Shimada H, Shimada K, Silva D, Sinclair B, Sperling S, Stupka E, Sugiura K, Sultana P. Takenaka Y, Taki K, Tammoja K, Tan SL, Tang S, Taylor MS, Tegner J, Teichmann SA, Ueda HR, van Nimwegen E, Verardo R, Wei CL, Yagi K, Yamanishi H, Zabarovsky E, Zhu S, Zimmer A, Hide W, Bult C, Grimmond SM, Teasdale RD, Liu ET, Brusic V, Quackenbush J, Wahlestedt C, Mattick JS, Hume DA, Kai C, Sasaki D, Tomaru Y, Fukuda S, Kanamori-Katayama M, Suzuki M, Aoki J, Arakawa T, Iida J, Imamura K, Itoh M, Kato T, Kawaji H, Kawagashira N, Kawashima T, Kojima M, Kondo S, Konno H, Nakano K, Ninomiya N, Nishio T, Okada M, Plessy C, Shibata K, Shiraki T, Suzuki S, Tagami M, Waki K, Watahiki A, Okamura-Oho Y, Suzuki H, Kawai J, Hayashizaki Y: The transcriptional landscape of the mammalian genome. Science 2005, 309(5740):1559-1563.
20. Kan Z, Rouchka EC, Gish WR, States DJ: Gene structure prediction and alternative splicing analysis using genomically aligned ESTs. Genome Res 2001, 11(5):889-900.
21. Kamat A, Hinshelwood MM, Murry BA, Mendelson CR: Mechanisms in tissue-specific regulation of estrogen biosynthesis in humans. Trends Endocrinol Metab 2002, 13(3):122-128.
22. Landry JR, Mager DL, Wilhelm BT: Complex controls: the role of alternative promoters in mammalian genomes. Trends Genet 2003, 19(11):640-648.
23. Phelps DE, Hsiao KM, Li Y, Hu N, Franklin DS, Westphal E, Lee EY, Xiong Y: Coupled transcriptional and translational control of cyclin-dependent kinase inhibitor p181NK4c expression during myogenesis. Mol Cell Biol 1998, 18(4):2334-2343.
24. Griffin E, Re A, Hamel N, Fu C, Bush H, McCaffrey T, Asch AS: A link between diabetes and atherosclerosis: Glucose regulates expression of CD36 at the level of translation. Nat Med 2001, 7(7):840-846.
25. Tang Y, Taylor KT, Sobieski DA, Medved ES, Lipsky RH: Identification of a human CD36 isoform produced by exon skipping. Conservation of exon organization and pre-mRNA splicing patterns with a CD36 gene family member, CLA-1. J Biol Chem 1994, 269(8):6011-6015.
26. Kern P, Kolowos W, Hagenhofer M, Frank C, Kalden JR, Herrmann M: Alternatively spliced mRNA molecules of the thrombospondin receptor (CD36) in human PBMC. Eur J Immunogenet 1999, 26(5):337-342.
27. Taylor KT, Tang Y, Sobieski DA, Lipsky RH: Characterization of two alternatively spliced 5′-untranslated exons of the human CD36 gene in different cell types. Gene 1993, 133(2):205-212.
28. Shiraki T, Kondo S, Katayama S, Waki K, Kasukawa T, Kawaji H, Kodzius R, Watahiki A, Nakamura M, Arakawa T, Fukuda S, Sasaki D, Podhajska A, Harbers M, Kawai J, Carninci P, Hayashizaki Y: Cap analysis gene expression for high-throughout analysis of transcriptional starting point and identification of promoter usage. Proc Natl Acad Sci USA 2003, 100(26):15776-15781.
29. Tontonoz P, Nagy L, Alvarez JG, Thomazy VA, Evans RM: PPAR-gamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 1998, 93(2):241-252.
30. Hiratsuka A, Adachi H, Fujiura Y, Yamagishi S, Hirai Y, Enomoto M, Satoh A, Hino A, Furuki K, Imaizumi T: Strong association between serum hepatocyte growth factor and metabolic syndrome. J Clin Endocrinol Metab 2005, 90(5):2927-2931.
31. Whatling C, Bjork H, Gredmark S, Hamsten A, Eriksson P: Effect of macrophage differentiation and exposure to mildly oxidized LDL on the proteolytic repertoire of THP-1 monocytes. J Lipid Res 2004, 45(9):1768-1776.
32. Morgan AR, Rerkasem K, Gallagher PJ, Zhang B, Morris GE, Calder PC, Grimble RF, Eriksson P, McPheat WL, Shearman CP, Ye S: Differences in matrix metalloproteinase-1 and matrix metalloproteinase-12 transcript levels among carotid atherosclerotic plaques with different histopathological characteristics. Stroke 2004, 35(6):1310-1315.
33. Amplification Efficiency of TaqMan® Gene Expression Assays [http://docs.appliedbiosystems.com/pebiodocs/00113186.pdf]
34. User Bulletin #2 [http://docs.appliedbiosystems.com/pebiodocs/04303859.pdf]
35. Quandt K, Frech K, Karas H, Wingender E, Werner T: MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res 1995, 23(23):4878-4884.
36. Sandelin A, Alkema W, Engstrom P, Wasserman WW, Lenhard B: JASPAR: an open-access database for eukaryotic transcription factor binding profiles. Nucleic Acids Res 2004:D91-94.
37. Sandelin A, Wasserman WW, Lenhard B: ConSite: web-based prediction of regulatory elements using cross-species comparison. Nucleic Acids Res 2004:W249-252.
38. Gibbs Motif Sampler [http://bayesweb.wadsworth.org/gibbs/gibbs.html]